Effectiveness and safety of first-line atezolizumab in locally advanced or metastatic urothelial cancer: The IMFLAME study.

被引：0
|
作者：
Lista, Alfonso Gomez De Liano
Romero-Laorden, Nuria
Gajate, Pablo
Orta-Ruiz, Alberto
Jimenez, Jesus Garcia-Donas
Miranda, Maria Jose
Estevez, Sergio Vazquez
Molins, Carmen
Pernaut, Cristina
Cordero, Marta Gonzalez
Fernandez, Ovidio
Sanchez, Jose Garcia
Maeso, Iria Gonzalez
Blazquez, Patricia Rodriguez
Reig, Oscar
Maroto-Rey, Pablo
Martin, Almudena
Ramirez, Ignacio
Puente, Javier
机构：
[1] Complejo Hosp Univ Insular Materno Infantil, Med Oncol Dept, Las Palmas Gran Canaria, Spain
[2] Univ Hosp La Princesa, Fdn Inst Roche Med Personalizada Precis, Med Oncol Dept, Catedra UAM, Madrid, Spain
[3] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[4] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain
[5] Ctr Integral Oncol Clara Campal CIOCC, Med Oncol Dept, Madrid, Spain
[6] Hosp Univ St Joan de Reus, Inst Oncol Catalunya Sud IOCS, Med Oncol Dept, IISPV,URV, Tarragona, Spain
[7] Univ Hosp Lucus Augusti, Med Oncol Dept, Lugo, Spain
[8] Univ Hosp Dr Peset, Med Oncol Dept, Valencia, Spain
[9] Univ Hosp Severo Ochoa, Med Oncol Dept, Leganes, Spain
[10] Univ Hosp Badajoz, Med Oncol Dept, Badajoz, Spain
[11] Complexo Hosp Univ Ourense, Med Oncol Dept, Orense, Spain
[12] Univ Hosp Arnau Vilanova, Fdn Fomento Invest Sanitaria & Biomed Comun Valenc, Med Oncol Dept, Valencia, Spain
[13] Univ Hosp Son Llatzer, Med Oncol Dept, Palma De Mallorca, Spain
[14] Univ Hosp Lluis Alcaniz Xativa, Med Oncol Dept, Valencia, Spain
[15] Hosp Clin Barcelona, Med Oncol Dept, Translat Genom & Targeted Therapeut Solid Tumors G, Barcelona, Spain
[16] Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain
[17] Roche Farma SA, Med Dept, Madrid, Spain
[18] Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.720
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2012, 18 (01): : 70 - 71
  • [2] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2011, 17 (07): : 638 - 639
  • [3] Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost-effectiveness analysis
    Zhang, Peng-Fei
    Wen, Feng
    Wu, Qiu-Ji
    Li, Qiu
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (14) : 1021 - 1030
  • [4] Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer
    Qin, Shuxia
    Yi, Lidan
    Li, Sini
    Tan, Chongqing
    Zeng, Xiaohui
    Wang, Liting
    Peng, Ye
    Wan, Xiaomin
    ADVANCES IN THERAPY, 2021, 38 (06) : 3399 - 3408
  • [5] Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer
    Shuxia Qin
    Lidan Yi
    Sini Li
    Chongqing Tan
    Xiaohui Zeng
    Liting Wang
    Ye Peng
    Xiaomin Wan
    Advances in Therapy, 2021, 38 : 3399 - 3408
  • [6] First line therapy for locally advanced or metastatic urothelial cancer
    Rexer, H.
    Ohlmann, C. -H.
    Gschwend, J.
    UROLOGE, 2017, 56 (10): : 1331 - 1332
  • [7] A drug safety evaluation of atezolizumab in locally advanced or metastatic urothelial carcinoma
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Bamias, Aristotelis
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (08) : 955 - 960
  • [8] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    Mansinho, Andre
    Cruz, Andreia
    Marconi, Lorenzo
    Pinto, Cidalia
    Augusto, Isabel
    ADVANCES IN THERAPY, 2023, 40 (10) : 4134 - 4150
  • [9] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    André Mansinho
    Andreia Cruz
    Lorenzo Marconi
    Cidália Pinto
    Isabel Augusto
    Advances in Therapy, 2023, 40 : 4134 - 4150
  • [10] A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC).
    Funt, Samuel Aaron
    Jatwani, Karan
    Makris, Michelle
    Regazzi, Ashley Marie
    Lee, Chung-Han
    Teo, Min Yuen
    McHugh, Deaglan Joseph
    Mccoy, Asia S.
    Hettich, Grace
    Wong, Phillip
    Abu-Akeel, Moshen
    Wolchok, Jedd D.
    Merghoub, Taha
    Al-Ahmadie, Hikmat
    Ostrovnaya, Irina
    Chaim, Joshua
    Durack, Jeremy C.
    Iyer, Gopa
    Bajorin, Dean F.
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345